4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-24-001269
CEO sold 3,732 shares at $29.96 ($111,811)
- CEO acquired 9,528 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-01-06 | Option exercise | +9,528 | 100,253 | D | ||
| DAVIS STEPHEN CEO | 2024-01-08 | Sale | −3,732 | $29.96 | $111,811 | 96,521 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2024-01-06 | Option exercise · Restricted Stock Units | −9,528 | 0 | D | ||
| Open-market sales · 3,732 sh · avg $29.96 · $111,811 | |||||||
Loading xslF345X05/doc4.xml…